Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 82 clinical trials
  • 0 views
  • 22 Sep, 2022
  • 48 locations
A 3-Arm, Randomized, Blinded, Active-Controlled, Phase II Study of RO7121661, a PD1-TIM3 Bispecific Antibody and RO7247669, a PD1-LAG3 Bispecific Antibody, Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus

patients with advanced or metastatic esophageal squamous-cell carcinoma (ESCC) refractory or intolerant to fluoropyrimidine- or taxane- and platinum-based regimen. Following approval of the protocol

  • 2 views
  • 16 Sep, 2022
  • 75 locations
NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy

neuropathy in cancer survivors who have completed chemotherapy with taxane or platinum-complex compounds between 1 and 12 months earlier.

cancer
hysterectomy
estradiol
ovarian cancer
paclitaxel
  • 34 views
  • 25 Mar, 2022
  • 1 location
A Phase 1b Trial Investigating Docetaxel Combined With Cirmtuzumab in Patients With Metastatic Castration Resistant Prostate Cancer

. Docetaxel is a taxane chemotherapy which has been shown to prolong survival in men with castration resistant prostate cancer. Cirmtuzumab is a monoclonal antibody that targets the receptor called ROR1 of

  • 0 views
  • 15 Sep, 2022
  • 1 location
A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

Taxane-induced peripheral neuropathy (TIPN) caused by paclitaxel is a dose-limiting toxicity. The main symptoms of discomfort are numbness, tingling, and burning sensations in the glove-sock

  • 0 views
  • 30 Apr, 2022
  • 1 location
Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma

greater than 5 years. In other soft tissue sarcomas, the use of radiotherapy and/or chemotherapy have improved progression-free survival in patients undergoing limited, organ-sparing surgeries. Taxane

  • 0 views
  • 23 Jul, 2022
  • 1 location
Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC

bone-damaging effects. There is an unmet medical need to develop steroid-free taxane regimens for patients with advanced cancer to avoid the need for steroid administration pre and post infusion

  • 0 views
  • 07 Jan, 2022
  • 3 locations
Neoadjuvant Carboplatin in Triple Negative Breast Cancer

neoadjuvant chemotherapy based on anthracycline and taxane, with or without carboplatin.

Accepts healthy volunteers
  • 2 views
  • 24 Feb, 2022
  • 1 location
Skin Sensitivity Acupuncture and Kinesiotherapy on Breast Cancer Patients Subject to Chemotherapy With Taxans (Acupuncture)

Objective: to compare different therapies employing acupuncture needles, silicon pellets and kinesiotherapy in breast cancer patients to taxane chemotherapy cycles. Methods:The present study

Accepts healthy volunteers
cancer
kinesiotherapy
chemotherapy cycles
immunomodulators
  • 1 views
  • 25 Mar, 2022
  • 1 location
Salvage Systemic Therapy With or Without Stereotactic Ablative Radiotherapy for Recurrent Ovarian Cancer (SABR-ROC)

effects with the introduction of taxane. Efforts have been made to find the role of salvage radiation therapy (RT) in recurrent ovarian cancer. Involved field radiotherapy (IFRT) emerged to cover the

  • 0 views
  • 25 Jul, 2022
  • 1 location